Aarti Drugs Limited — Important, 24-09-2025: Updates
24-09-2025 | 08:34 pm
24-09-2025 | 08:34 pm
Aarti Drugs has nearly completed its Rs. 600 Cr capex, bringing new plants (Salicylic Acid, Sayakha greenfield) online, driving capacity growth and market expansion. Q1 FY26 revenue rose 6% to Rs. 591 Cr, with PAT up 63% to Rs. 54 Cr, signaling a strong rebound after FY25's slight dip.
No comments yet. Be the first to comment!
